Ohio Public Employees Retirement System (OPERS)’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-59,354
Closed -$170K 2427
2024
Q3
$170K Hold
59,354
﹤0.01% 1570
2024
Q2
$173K Sell
59,354
-3,591
-6% -$9.82K ﹤0.01% 1380
2024
Q1
$201K Buy
62,945
+40,245
+177% +$134K ﹤0.01% 1348
2023
Q4
$76.3K Buy
+22,700
New +$58.5K ﹤0.01% 1463
2022
Q1
Sell
-22,903
Closed -$156K 2057
2021
Q4
$156K Sell
22,903
-1,000
-4% -$6.81K ﹤0.01% 1582
2021
Q3
$174K Sell
23,903
-1,000
-4% -$8.58K ﹤0.01% 1557
2021
Q2
$250K Hold
24,903
﹤0.01% 1458
2021
Q1
$238K Buy
24,903
+21,703
+678% +$213K ﹤0.01% 1441
2020
Q4
$35K Buy
+3,200
New +$33.7K ﹤0.01% 1898

Other funds holding PSTX

Ohio Public Employees Retirement System (OPERS)'s PSTX Position: Q4 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q4 2024, closing a stake of 59,354 shares — an estimated $170K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in PSTX in Q4 2020 and held it in 9 quarters. The position peaked at $250K in Q2 2021. 115 funds tracked by Wall St. Rank hold PSTX as of Q4 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 59,354 Poseida Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $170K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Poseida Therapeutics, Inc. Common Stock position peaked at $250K in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2024, filed 19 Feb 2025.